期刊文献+

三苯氧胺联合化疗对人大肠癌细胞系SW480、HT29的作用 被引量:1

The effects of tamoxifen combining with chemotherapy in human colorectal carcinoma cell line SW480, HT29
下载PDF
导出
摘要 目的 研究三苯氧胺联合化疗药物对人结肠癌细胞系SW 4 80、HT2 9体外培养的影响及机制探讨。方法 应用MTT法 ,比较单纯用三苯氧胺和三苯氧胺与化疗药物联合对SW4 80、HT2 9细胞系生长抑制作用 ,通过化疗药物的量—效关系曲线 ,观察三苯氧胺有否化疗增敏作用 ,同时对mdr1编码产物Pgp的检测 ,探讨三苯氧胺可能的作用机制。 结果 在TAM浓度为 5 μmol/L时 ,能使SW4 80细胞系对 5 FU、MTX的敏感性分别提高 1.5 976、1.6 4 5 6倍 ;在 10 μmol/L时 ,使SW 4 80、HT2 9细胞系对 5 FU、MMC、MTX、ADM的敏感性分别提高 4 .15 2 4、2 .0 2 4 4、4 .7833、2 .2 32 3倍和 4 .7713、4 .786 5、4 .2 5 5 7、4 .4 713倍 ,差别有显著性 (P <0 .0 5 )。化疗药物使体外培养的SW 4 80、HT2 9细胞系产生耐药性 (P1,P2 <0 .0 5 ) ,TAM能显著逆转其耐药性 (P3,P4 <0 .0 5 )。结论 在体外实验中 ,一定浓度的TAM能增加人结肠癌细胞系SW 4 80、HT2 9对化疗药物 5 FU、MMC、MTX、ADM的敏感性 ,其机制可能为TAM抑制mdr1编码产物P gp的产生。 Objective To evaluate the possible effects of tamoxifen combining with chemotherapy in human colorectal carcinoma cell lines SW480、HT29. Methods Tetrazolium(MTT) assay was used and the inhibition effects were compared in cultures of SW480 and HT29 with tamoxifen alone and with tamoxifen combining with chemotherapy, and observed the possible mechanism of whether tamoxifen could increase the chemosensitization or not by detected mdrl coded P-gp.Results Tamoxifen at concentration of 5 μmol/L increased the chemosensitivity of 5-FU and MTX by 1.5976 to 1.6456-fold in SW480 cell line.Tamoxifen at concentration of 10 μmol/L increased the chemosensitivity of 5-FU、MMC、MTX、ADM by 4.1524、2.0244、4.7833 to 2.2323-fold respectively in SW480 cell line and increased 4.7713、4.7865、4.2557、4.4713-fold in HT29 cell line(P<0.05) respectively. Chemotherapy durgs caused the cultural SW480 and HT29 cell lines in vitro to produce drug resistence (P1,P2<0.05) , while Tmoxifen could significantly reverse (P3,P4<0.05).Conclusion In vitro,Tamoxifen can enhance the chemosensitivity of 5-FU、MMC、MTX、ADM at different concentrations and its possible mechanism is that Tamoxifen inhibits the increase of mdr1 mode P-gp.
出处 《肿瘤》 CAS CSCD 北大核心 2003年第6期471-474,共4页 Tumor
基金 武汉大学中南医院肿瘤科 (武汉 43 0 0 71)
关键词 三苯氧胺 联合化疗 大肠癌 细胞系 SW480 HT29 Tamoxifen Half inhibition concentration Multidrug resistance Chemotherapy Colorectal carcinoma
  • 相关文献

参考文献3

二级参考文献22

  • 1李楠.p16基因与肿瘤[J].国外医学(肿瘤学分册),1995,22(5):257-259. 被引量:17
  • 2陆哲明.p16抑癌基因的发现及研究[J].国外医学(肿瘤学分册),1995,22(6):321-323. 被引量:20
  • 3郑德先.细胞凋亡的研究进展[J].中华病理学杂志,1996,25(1):50-53. 被引量:47
  • 4郭在培.细胞凋亡的研究进展[J].国外医学(皮肤性病学分册),1996,22(6):331-333. 被引量:16
  • 5施作霖 陈林 等.P糖蛋白和谷胱苷肽-S-转移酶在肾细胞癌中的表达[J].临床与实验病理学杂志,1998,14(2):132-132.
  • 6[1]Motoo Y, Su SB, Nakatani MT, et al. Expression of multidrug resistance gene (mdr-1) mRNA in gastric and colorectal cancer [J]. Anticancer Res, 1998;18:1903
  • 7[2]Meijer GA, Schroeijers AB, Flens MJ, et al. Increased expres sion of multidrug resistance related proteins PgP, MRPI and LRPMVP occurs early in colorectal carcinogenesis [J]. Clin Pathol, 1999;52(6) :450
  • 8[3]Wang QJ, Beck WT. Transcriptional suppression of multidrug re sistance associated protein (MRP) gene expression by wild-type p53[J]. Cancer Res, 1998; 58(24): 5762.
  • 9[4]Peters WH, Boon CE, Roelofs HM, et al. Expression of drug metabolizing enzymes and P-170 glycoprotein in colorectal carci norna and normal mucosa [J]. Gastroenterology, 1992; 103 ( 2 ):448
  • 10[5]De Angelis P, Stokke T, Smedshammer L, et al. P-glycoprotein is not expressed in a majority of coloreeful carcinomas and is not rehulated by mutant p53 in vivo [J]. Br J Caner, 1995; 72 (2):307

共引文献18

同被引文献24

  • 1MARINA N, GEBHARDT M, TEOT L, et al. Biology and therapeutic advances for pediatric osteosarcoma[J]. Oncologist, 2004, 9(4):422-441.
  • 2LEWIS V O, RAYMOND K, MIRZA A N, et al. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response[J]. C/in Orthop Related Res, 2006, 450:60-66.
  • 3GOKLSBY R, BURKE C, NAGARAJAN R, et al. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort[J]. Cancer, 2008, 113(9): 2597-2604.
  • 4MANSKY P, ARAI A, STRAI-I'ON P, et al. Treatment late effects in long-term survivors of pediatric sarcoma[J]. Pediatr Blood Cancer, 2007, 48(2):192-199.
  • 5DOHI O, HATORI M, SUZUKI T, et al. Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma[J]. Cancer Sci, 2008, 99(3):518-523.
  • 6MERK O, SPELT G. Detection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity[J]. Environ Mol Mutagen, 1999, 33(2):167-172.
  • 7ZHENG A, KALLIO A, HARKONEN P. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen[J]. Endocrinology, 2007, 148(6):2764-2777.
  • 8TAN C K, CHOW P K, FINDLAY M, et al. Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift[J]. J Gastroenterol Hepatol, 2000, 15(7):725-729.
  • 9WILLIAMS M D, ROBERTS D, BLUMENSCHEIN G R Jr, et al. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients[J]. Am J Surg Pathol, 2007, 31(11):1645-1652.
  • 10MOTYLEWSKA E, t_AWNICKA H, MEtEN-MUCHA G. Oestradiol and tamoxifen inhibit murine Colon 38 cancer growth and increase the cytotoxic effect of fluorouracil[J]. Endokrynol Pol, 2007, 58(5):426-434.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部